(18)F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study

Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein-1 (PD-1)/programmed cell death ligand-1 (PD-L1) frequently induces tumor response in metastatic melanoma patients. However, tumor response often takes months and may be heterogeneous. Consequently, additional local treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Nienhuis, Pieter H., Antunes, Inês F., Glaudemans, Andor W.J.M., Jalving, Mathilde, Leung, David, Noordzij, Walter, Slart, Riemer H.J.A., de Vries, Erik F.J., Hospers, Geke A.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2022
Materias:
Clinical (Oncology: Melanoma/Skin)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157735/
https://www.ncbi.nlm.nih.gov/pubmed/34503964
http://dx.doi.org/10.2967/jnumed.121.262368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157735/
https://www.ncbi.nlm.nih.gov/pubmed/34503964
http://dx.doi.org/10.2967/jnumed.121.262368

Ejemplares similares